Literature DB >> 32498098

Endoscopic ultrasound-guided tissue acquisition with or without macroscopic on-site evaluation: randomized controlled trial.

Charing C N Chong1, Sundeep Lakhtakia2, Nam Nguyen3, Kazuo Hara4, Wah Kheong Chan5, Rajesh Puri6, Majid A Almadi7, Tiing Leong Ang8, Andrew Kwek8, Ichiro Yasuda9, Shinpei Doi9, Mitsuhiro Kida10, Hsiu-Po Wang11, Tsu-Yao Cheng11, Qingwei Jiang12, Aiming Yang12, Anthony W H Chan13, Shannon Chan1, Raymond Tang14, Takuji Iwashita15, Anthony Y B Teoh1.   

Abstract

BACKGROUND: The use of macroscopic on-site evaluation (MOSE) to estimate the adequacy of a specimen for histological diagnosis during endoscopic ultrasound (EUS)-guided fine-needle tissue acquisition (FNTA) has recently been advocated. This study aimed to evaluate the diagnostic yield of MOSE compared with conventional EUS-FNTA without rapid on-site evaluation (ROSE).
METHODS: This was an international, multicenter, prospective, randomized controlled study. After providing informed consent, consecutive adult patients referred for EUS-FNTA for solid lesions larger than 2 cm were randomized to a MOSE arm or to a conventional arm without ROSE. A designated cytopathologist from each center performed all cytopathological examinations for that center and was blinded to the randomization results. The primary outcome measure was the diagnostic yield, and the secondary outcomes included sensitivity, specificity, positive predictive value, negative predictive value, diagnostic accuracy, and the rate of procedure-related complications.
RESULTS: 244 patients (122 conventional, 122 MOSE) were enrolled during the study period. No significant differences between the two arms were found in procedure time or rate of procedure-related adverse events. The diagnostic yield for the MOSE technique (92.6 %) was similar to that for the conventional technique (89.3 %; P  = 0.37), with significantly fewer passes made (median: conventional 3, MOSE 2; P  < 0.001).
CONCLUSIONS: EUS-FNTA with the MOSE technique provided a similar diagnostic yield to conventional EUS-FNTA technique in the absence of ROSE but with fewer passes. This technique can be used when ROSE is not available. Thieme. All rights reserved.

Entities:  

Mesh:

Year:  2020        PMID: 32498098     DOI: 10.1055/a-1172-6027

Source DB:  PubMed          Journal:  Endoscopy        ISSN: 0013-726X            Impact factor:   10.093


  8 in total

1.  Macroscopic on-site evaluation after EUS-guided fine needle biopsy may replace rapid on-site evaluation.

Authors:  Hoonsub So; Dong-Wan Seo; Jun Seong Hwang; Sung Woo Ko; Dongwook Oh; Tae Jun Song; Do Hyun Park; Sung Koo Lee; Myung-Hwan Kim
Journal:  Endosc Ultrasound       Date:  2021 Mar-Apr       Impact factor: 5.628

2.  Usefulness of Macroscopic On-Site Evaluation Using a Stereomicroscope during EUS-FNB for Diagnosing Solid Pancreatic Lesions.

Authors:  Takuya Ishikawa; Eizaburo Ohno; Yasuyuki Mizutani; Tadashi Iida; Kota Uetsuki; Jun Yashika; Kenta Yamada; Noriaki Gibo; Toshinori Aoki; Kunio Kataoka; Hiroshi Mori; Yoshihisa Takada; Hidekazu Takahashi; Hironori Aoi; Katsuyuki Kato; Takeshi Yamamura; Naomi Kakushima; Kazuhiro Furukawa; Masanao Nakamura; Yoshiki Hirooka; Hiroki Kawashima
Journal:  Can J Gastroenterol Hepatol       Date:  2022-01-18

3.  Endoscopic Ultrasound-Guided Fine-Needle Biopsy Using 22G Franseen Needles without Rapid On-Site Evaluation for Diagnosis of Intraabdominal Masses.

Authors:  Nonthalee Pausawasdi; Kunsuda Cheirsilpa; Wipapat Chalermwai; Ishan Asokan; Tassanee Sriprayoon; Phunchai Charatcharoenwitthaya
Journal:  J Clin Med       Date:  2022-02-17       Impact factor: 4.241

4.  Impact of Macroscopic On-Site Evaluation (MOSE) on Accuracy of Endoscopic Ultrasound-Guided Fine-Needle Biopsy (EUS-FNB) of Pancreatic and Extrapancreatic Solid Lesions: A Prospective Study.

Authors:  Silvia Gaia; Stefano Rizza; Mauro Bruno; Davide Giuseppe Ribaldone; Francesca Maletta; Marco Sacco; Donatella Pacchioni; Felice Rizzi; Giorgio Maria Saracco; Sharmila Fagoonee; Claudio Giovanni De Angelis
Journal:  Diagnostics (Basel)       Date:  2022-02-07

5.  Development of a Novel Evaluation Method for Endoscopic Ultrasound-Guided Fine-Needle Biopsy in Pancreatic Diseases Using Artificial Intelligence.

Authors:  Takuya Ishikawa; Masato Hayakawa; Hirotaka Suzuki; Eizaburo Ohno; Yasuyuki Mizutani; Tadashi Iida; Mitsuhiro Fujishiro; Hiroki Kawashima; Kazuhiro Hotta
Journal:  Diagnostics (Basel)       Date:  2022-02-08

6.  Tumor Location in the Head/Uncinate Process and Presence of Fibrosis Impair the Adequacy of Endoscopic Ultrasound-Guided Tissue Acquisition of Solid Pancreatic Tumors.

Authors:  Thomas Togliani; Andrea Lisotti; Rosa Rinaldi; Adele Fornelli; Stefano Pilati; Nicola Passigato; Pietro Fusaroli
Journal:  Cancers (Basel)       Date:  2022-07-21       Impact factor: 6.575

7.  Macroscopic on-site evaluation (MOSE) of specimens from solid lesions acquired during EUS-FNB: multicenter study and comparison between needle gauges.

Authors:  Benedetto Mangiavillano; Leonardo Frazzoni; Thomas Togliani; Carlo Fabbri; Ilaria Tarantino; Luca De Luca; Teresa Staiano; Cecilia Binda; Marianna Signoretti; Leonardo H Eusebi; Francesco Auriemma; Laura Lamonaca; Danilo Paduano; Milena Di Leo; Silvia Carrara; Lorenzo Fuccio; Alessandro Repici
Journal:  Endosc Int Open       Date:  2021-05-27

8.  The diagnostic performance of combined conventional cytology with smears and cell block preparation obtained from endoscopic ultrasound-guided fine needle aspiration for intra-abdominal mass lesions.

Authors:  Nonthalee Pausawasdi; Penprapai Hongsrisuwan; Wipapat Vicki Chalermwai; Amna Subhan Butt; Kotchakon Maipang; Phunchai Charatchareonwitthaya
Journal:  PLoS One       Date:  2022-03-23       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.